AI assistant
Sending…
Skye Bioscience, Inc. — Director's Dealing 2015
Apr 16, 2015
34097_dirs_2015-04-16_724a974f-244b-46d6-b6ed-9a7dd8dd1e15.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Nemus Bioscience, Inc. (NMUS)
CIK: 0001516551
Period of Report: 2015-04-03
Reporting Person: Squires Richard D. (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1485000 | Direct |
| Common Stock | 15000 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Common Stock Warrant (right to buy) | $1 | 2019-06-04 | Common Stock (371250) | Direct | |
| Common Stock Warrant (right to buy) | $1 | 2019-06-04 | Common Stock (3750) | Indirect |
Footnotes
F1: Represents shares of Common Stock directly owned by RS Holdings, Inc.
F2: Represents shares of Common Stock Warrants directly owned by RS Holdings, Inc.
F3: Mr. Squires disclaims beneficial ownership of any securities directly owned by RS Holdings, Inc. reported herein except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all such shares for purposes of Section 16 or for any other purpose.
More from Skye Bioscience, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
May 29
Delisting Announcement
2026
May 15
Annual Report
2026
Apr 16
Proxy Solicitation & Information Statement
2026
Apr 16
Board/Management Information
2026
Apr 3
Delisting Announcement
2026
Mar 19
Board/Management Information
2026
Feb 20
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10